can i take glp 1 without diabetes GLP-1 Agonists In Obesity GLP-1 use: More people without

Combination immunotherapies for type 1 diabetes mellitus

Hypoglycemia risk: Patients taking GLP-1 agonists with insulin or sulfonylureas need close glucose monitoring, as dose adjustments of these medications may be necessary

He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, et al

Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations (8.4)]